These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 15896958

  • 1. Acyclic cyanamide-based inhibitors of cathepsin K.
    Barrett DG, Deaton DN, Hassell AM, McFadyen RB, Miller AB, Miller LR, Payne JA, Shewchuk LM, Willard DH, Wright LL.
    Bioorg Med Chem Lett; 2005 Jun 15; 15(12):3039-43. PubMed ID: 15896958
    [Abstract] [Full Text] [Related]

  • 2. Novel and potent cyclic cyanamide-based cathepsin K inhibitors.
    Deaton DN, Hassell AM, McFadyen RB, Miller AB, Miller LR, Shewchuk LM, Tavares FX, Willard DH, Wright LL.
    Bioorg Med Chem Lett; 2005 Apr 01; 15(7):1815-9. PubMed ID: 15780613
    [Abstract] [Full Text] [Related]

  • 3. Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.
    Altmann E, Green J, Tintelnot-Blomley M.
    Bioorg Med Chem Lett; 2003 Jun 16; 13(12):1997-2001. PubMed ID: 12781182
    [Abstract] [Full Text] [Related]

  • 4. Potent dipeptidylketone inhibitors of the cysteine protease cathepsin K.
    Marquis RW, Ru Y, Yamashita DS, Oh HJ, Yen J, Thompson SK, Carr TJ, Levy MA, Tomaszek TA, Ijames CF, Smith WW, Zhao B, Janson CA, Abdel-Meguid SS, D'Alessio KJ, McQueney MS, Veber DF.
    Bioorg Med Chem; 1999 Apr 16; 7(4):581-8. PubMed ID: 10353637
    [Abstract] [Full Text] [Related]

  • 5. Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
    Tavares FX, Boncek V, Deaton DN, Hassell AM, Long ST, Miller AB, Payne AA, Miller LR, Shewchuk LM, Wells-Knecht K, Willard DH, Wright LL, Zhou HQ.
    J Med Chem; 2004 Jan 29; 47(3):588-99. PubMed ID: 14736240
    [Abstract] [Full Text] [Related]

  • 6. Discovery of selective and nonpeptidic cathepsin S inhibitors.
    Irie O, Ehara T, Iwasaki A, Yokokawa F, Sakaki J, Hirao H, Kanazawa T, Teno N, Horiuchi M, Umemura I, Gunji H, Masuya K, Hitomi Y, Iwasaki G, Nonomura K, Tanabe K, Fukaya H, Kosaka T, Snell CR, Hallett A.
    Bioorg Med Chem Lett; 2008 Jul 15; 18(14):3959-62. PubMed ID: 18572405
    [Abstract] [Full Text] [Related]

  • 7. 3-Acylamino-azetidin-2-one as a novel class of cysteine proteases inhibitors.
    Zhou NE, Guo D, Thomas G, Reddy AV, Kaleta J, Purisima E, Menard R, Micetich RG, Singh R.
    Bioorg Med Chem Lett; 2003 Jan 06; 13(1):139-41. PubMed ID: 12467634
    [Abstract] [Full Text] [Related]

  • 8. Novel, nonpeptidic cyanamides as potent and reversible inhibitors of human cathepsins K and L.
    Falgueyret JP, Oballa RM, Okamoto O, Wesolowski G, Aubin Y, Rydzewski RM, Prasit P, Riendeau D, Rodan SB, Percival MD.
    J Med Chem; 2001 Jan 04; 44(1):94-104. PubMed ID: 11141092
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized rat.
    Lark MW, Stroup GB, James IE, Dodds RA, Hwang SM, Blake SM, Lechowska BA, Hoffman SJ, Smith BR, Kapadia R, Liang X, Erhard K, Ru Y, Dong X, Marquis RW, Veber D, Gowen M.
    Bone; 2002 May 04; 30(5):746-53. PubMed ID: 11996914
    [Abstract] [Full Text] [Related]

  • 14. Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin K.
    Duffy KJ, Ridgers LH, DesJarlais RL, Tomaszek TA, Bossard MJ, Thompson SK, Keenan RM, Veber DF.
    Bioorg Med Chem Lett; 1999 Jul 19; 9(14):1907-10. PubMed ID: 10450951
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and evaluation of keto-glutamine analogues as inhibitors of hepatitis A virus 3C proteinase.
    Ramtohul YK, James MN, Vederas JC.
    J Org Chem; 2002 May 17; 67(10):3169-78. PubMed ID: 12003522
    [Abstract] [Full Text] [Related]

  • 16. Synthesis of peptide aldehyde derivatives as selective inhibitors of human cathepsin L and their inhibitory effect on bone resorption.
    Yasuma T, Oi S, Choh N, Nomura T, Furuyama N, Nishimura A, Fujisawa Y, Sohda T.
    J Med Chem; 1998 Oct 22; 41(22):4301-8. PubMed ID: 9784105
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biotin-labelled peptidyl diazomethane inhibitors derived from the substrate-like sequence of cystatin: targeting of the active site of cruzipain, the major cysteine proteinase of Trypanosoma cruzi.
    Lalmanach G, Mayer R, Serveau C, Scharfstein J, Gauthier F.
    Biochem J; 1996 Sep 01; 318 ( Pt 2)(Pt 2):395-9. PubMed ID: 8809025
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.